← Leaderboards
Eric G. Smith
Edith Nourse Rogers Memorial Veterans Hospital
$0
Attributed
$0
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2017–25$1$1$1$0$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
VA$0 · 4
By mechanism
I01$0 · 3
I21$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Edith Nourse Rogers Memorial Veterans Hospital
Same institution · by research overlap
Others in their field
Other Emerging Leaders on “Suicide Prevention”
- Molly Adrian · Seattle Children'S Hospital$9,535,700
- Ewa Karina Czyz · University Of Michigan At Ann Arbor$6,907,667
- Miriam Komaromy · Rand Corporation$6,641,933
- Melanie Bozzay · Butler Hospital (Providence, Ri)$5,357,481
- Arielle Hope Sheftall · Research Inst Nationwide Children'S Hosp$4,738,181
- Teresa Brockie · Johns Hopkins University$4,424,635
Research focus
Suicide PreventionMental HealthProviderVeteransSafetyReportingPharmaceutical PreparationsDiagnosisSuicidal BehaviorCharacteristicsSubgroupMonitorDoseMortalityInvestigationRisk AssessmentHigh Risk PopulationHospitalizationHigh RiskSignal TransductionCaringBaseRisk FactorsPrograms
Grant awards (14)
Identifying Safe Stimulant Prescribing Practices to Protect Patients, Inform Key Program Initiatives, and Assist Providers$0
I01 · FY2025 · VA · contact PI
Identifying Best Practices for Medication-Based Suicide Prevention Strategies to Minimize the Risk of Medically-Serious Adverse Events$0
I01 · FY2024 · VA · contact PI
Identifying Best Practices for Medication-Based Suicide Prevention Strategies to Minimize the Risk of Medically-Serious Adverse Events$0
I01 · FY2024 · VA · contact PI
Identifying Safe Stimulant Prescribing Practices to Protect Patients, Inform Key Program Initiatives, and Assist Providers$0
I01 · FY2024 · VA · contact PI
Identifying Best Practices for Medication-Based Suicide Prevention Strategies to Minimize the Risk of Medically-Serious Adverse Events$0
I01 · FY2023 · VA · contact PI
Identifying Safe Stimulant Prescribing Practices to Protect Patients, Inform Key Program Initiatives, and Assist Providers$0
I01 · FY2022 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2021 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2021 · VA · contact PI
Identifying Best Practices for Medication-Based Suicide Prevention Strategies to Minimize the Risk of Medically-Serious Adverse Events$0
I01 · FY2020 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2020 · VA · contact PI
Enhancing Lithium's use in the VA through the design, initial use, and assessment of the Lithium Support System (the ELeVAte Study)$0
I21 · FY2020 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2019 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2018 · VA · contact PI
Assessing Actigraphy-Determined Movement Variability as a Novel Objective Marker of Suicidal Ideation and Behavior Risk in Veterans and Its Role in Integrated Suicide Risk Assessment$0
I01 · FY2017 · VA · contact PI